This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: Tomoko Chikatsu: Innovator in Protein Binding Screening
Introduction
Tomoko Chikatsu is a notable inventor based in Ibaraki, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of methods for screening compounds that alter protein binding properties. Her work has implications for the treatment of various diseases, showcasing her impact on medical research.
Latest Patents
Tomoko Chikatsu holds a patent for a "Method for screening compounds which change the binding properties of a protein with a ligand." This invention relates to a screening method and kit designed to identify compounds or their salts that modify the binding characteristics of specific proteins. The compounds discovered through this method are valuable for developing treatments for neurodegenerative diseases, immunological disorders, and other health issues.
Career Highlights
Chikatsu is currently associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research. Her innovative approach to protein binding has positioned her as a key figure in pharmaceutical development.
Collaborations
Tomoko collaborates with esteemed colleagues, including Toshimi Nagi and Tsukasa Sugo, enhancing the research environment and fostering innovation within her team.
Conclusion
Tomoko Chikatsu's contributions to the field of protein binding screening exemplify her dedication to advancing medical science. Her patent and ongoing work at Takeda Pharmaceutical Company Limited highlight her role as a leading inventor in biochemistry.